minoxidil

The drug is used to treat androgenetic alopecia. The 20 mg/ml concentration solution is suitable for both men and women aged 18 to 65, while the 50 mg/ml concentration solution is intended for men only within the same age range.

Form: solution, topical

ATC: D11AX01

Manufacturer: Belupo, Medicines and Cosmetics, d.d. (secondary packaging, quality control and batch release)

The drug is used to treat androgenetic alopecia (hair loss). The 2% solution is suitable for both men and women, while the 5% solution is intended for men only.

Form: solution, topical

ATC: D11AX01

Manufacturer: Belupo, Medicines and Cosmetics, d.d. (secondary packaging, quality control and batch release)

The drug is used to treat alopecia (hair loss) of the male pattern. The 2% variant is suitable for both men and women, while the 5% variant is intended for men only.

Form: solution, topical

ATC: D11AX01

Manufacturer: Industrial Farmaceutica Cantabria, S.A.

The product is intended for adults (men and women) with moderate hair loss caused by androgenetic alopecia. It helps stabilize hair loss and stimulates new hair growth.

Form: spray, topical solution

ATC: D11AX01

Manufacturer: Mibe GmbH Arzneimittel

The drug is intended for men with moderate hair loss (androgenetic alopecia).

Form: spray, topical solution

ATC: D11AX01

Manufacturer: Mibe GmbH Arzneimittel

The drug is used to stimulate hair growth in androgenetic alopecia. The 2% version is suitable for both men and women, while the 5% version is intended for men only.

Form: solution, topical

ATC: D11AX01

Manufacturer: Industrial Farmaceutica Cantabria, S.A.

The preparation is used for the treatment of androgenetic alopecia in both women and men.

Form: spray, topical solution

ATC: D11AX01

Manufacturer: Bosnaliek d.d.

The drug is indicated for the treatment of male pattern alopecia (hair loss in men).

Form: spray, topical solution

ATC: D11AX01

Manufacturer: Bosnaliek d.d.